FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.12  |  FHIR Version n/a  User: [n/a]

18233711000001101: Vimovo 500mg/20mg modified-release tablets (Grunenthal Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 15-Dec 2010. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
92791000001112 Vimovo 500mg/20mg modified-release tablets (Grunenthal Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
92801000001111 Vimovo 500mg/20mg modified-release tablets (Grunenthal Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Vimovo 500mg/20mg modified-release tablets (Grunenthal Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Vimovo 500mg/20mg modified-release tablets (Grunenthal Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Vimovo 500mg/20mg modified-release tablets (Grunenthal Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Vimovo 500mg/20mg modified-release tablets (Grunenthal Ltd) Is a Naproxen 500mg / Esomeprazole 20mg modified-release tablets true Inferred relationship Existential restriction modifier
Vimovo 500mg/20mg modified-release tablets (Grunenthal Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Vimovo 500mg/20mg modified-release tablets (Grunenthal Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Vimovo 500mg/20mg modified-release tablets (Grunenthal Ltd) Has specific active ingredient Naproxen true Inferred relationship Existential restriction modifier
Vimovo 500mg/20mg modified-release tablets (Grunenthal Ltd) Has specific active ingredient Esomeprazole magnesium trihydrate false Inferred relationship Existential restriction modifier
Vimovo 500mg/20mg modified-release tablets (Grunenthal Ltd) Has dispensed dose form Modified-release oral tablet true Inferred relationship Existential restriction modifier
Vimovo 500mg/20mg modified-release tablets (Grunenthal Ltd) Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Esomeprazole true Inferred relationship Existential restriction modifier
Vimovo 500mg/20mg modified-release tablets (Grunenthal Ltd) Has excipient Polysorbate false Inferred relationship Existential restriction modifier
Vimovo 500mg/20mg modified-release tablets (Grunenthal Ltd) Has excipient Hydroxybenzoates false Inferred relationship Existential restriction modifier
Vimovo 500mg/20mg modified-release tablets (Grunenthal Ltd) Has excipient Propylene glycol false Inferred relationship Existential restriction modifier
Vimovo 500mg/20mg modified-release tablets (Grunenthal Ltd) Is a Vimovo true Inferred relationship Existential restriction modifier
Vimovo 500mg/20mg modified-release tablets (Grunenthal Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Vimovo 500mg/20mg modified-release tablets (Grunenthal Ltd) Has active ingredient Naproxen true Inferred relationship Existential restriction modifier
Vimovo 500mg/20mg modified-release tablets (Grunenthal Ltd) Has active ingredient Esomeprazole true Inferred relationship Existential restriction modifier
Vimovo 500mg/20mg modified-release tablets (Grunenthal Ltd) Has manufactured dose form Modified-release oral tablet true Inferred relationship Existential restriction modifier
Vimovo 500mg/20mg modified-release tablets (Grunenthal Ltd) Has specific active ingredient Esomeprazole magnesium trihydrate true Inferred relationship Existential restriction modifier
Vimovo 500mg/20mg modified-release tablets (Grunenthal Ltd) Has basis of strength substance Esomeprazole true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Vimovo 500mg/20mg modified-release tablets (Grunenthal Ltd) 60 tablet Has AMP True Vimovo 500mg/20mg modified-release tablets (Grunenthal Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start